Naran Krupa (Dr)
Dr. Naran received her undergraduate training from The University of the Witwatersrand (WITS), majoring in microbiology & biotechnology and genetics & developmental biology (2006). Her postgraduate specialization in molecular and cell biology (Hons & MSc) was completed at WITS, while she received her PhD in medical microbiology from the University of Cape Town (2007 – 2015) – strengthening her expertise in the research area of preclinical tuberculosis (TB) drug discovery.
Subsequently, Dr. Naran reformed her research expertise to cancer immunotherapy and as such, she is the Head of Antibody Engineering at UCT’s Medical Biotechnology and Immunotherapy (MBI) Unit. She coordinates the R&D of MBI’s 20-member team and is instrumental in establishing bilateral collaborations with international researchers.
Dr. Naran has been recognized and awarded for excellence by several prestigious organizations including Carnegie’s Next Generation of Academics in Africa (NGAA) program, a Research Internship at AstraZeneca India funded by a Bioventures for Global Health (BVGH)/WIPO Re:Search Fellowship Program, and most recently, awarded a fellowship within the DST-NRF Research Professional Development Programme (PDP), which acknowledges scientists of the highest calibre and is tailored to accelerate the development of researchers who are poised to contribute to South Africa’s innovation platforms.[/vc_column_text][vc_empty_space height=”80px”][/vc_column][/vc_row]